ENTITY

Dogwood Therapeutics (DWTX US)

4
Analysis
Health CareUnited States
Dogwood Therapeutics, Inc. operates as a development-stage biotechnology. The Company develops novel therapeutics and sodium channel blocker to treat moderate-to-severe chemotherapy induced neuropathic pain, cancer pain, and other pain indications. Dogwood Therapeutics serves patients in the United States.
more
Company Event01 Mar 2025 01:30 • Upcoming
Add To Calendar
Company Event11 Nov 2024 21:30 • Upcoming
Add To Calendar
Company Event07 Nov 2024 21:30 • Latest
x